https://www.selleckchem.com/pr....oducts/ulixertinib-b
82; 95% confidence interval [CI], 0.51-1.34; p= 0.433) or for early versus late cohorts (adjusted OR; 1.04; 95% CI, 0.68-1.60; p=0.856). Following STEMI regionalization, women continued to experience significantly longer reperfusion times, although there was no difference in adjusted mortality. These results highlight the ongoing disparity of STEMI care between women and men, and suggest that regionalization alone is insufficient to close sex-based care gaps. Following STEMI regionalization, women continued to expe
Like
Comment
Share
